Status:

COMPLETED

Dexmedetomidine for Bilateral Superficial Cervical Plexus Block for Reconstructive Tracheal Surgery

Lead Sponsor:

Mansoura University

Conditions:

Tracheal Reconstruction

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

Tracheal resection and reconstruction (TRR) is the treatment of choice for most patients with tracheal stenosis or tracheal tumors .The post intubation tracheal stenosis is the common indication for (...

Detailed Description

The aim of this study is to evaluate the intra- and postoperative efficacy of levobupivacaine versus levobupivacaine - dexmedetomidine for superficial cervical plexus block for upper tracheal resectio...

Eligibility Criteria

Inclusion

  • American Society of Anesthesiologists physical status I or II.

Exclusion

  • History of allergy to the drugs used
  • Coagulation disorders
  • Pregnancy
  • Postpartum period.
  • Lactating females
  • Local sepsis

Key Trial Info

Start Date :

March 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2018

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT03426527

Start Date

March 1 2018

End Date

October 1 2018

Last Update

September 11 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mansoura University, Central Hospital, Oto-Rhino-Laryngology anesthesia Unit

Al Mansurah, DK, Egypt, 050